| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Log Kd | = | -9.23 |
| Log Kd | = | -9.52 |
| Log Kd | = | -9.01 |
| Log Kd | = | -7.71 |
| Log Kd | = | -6.11 |
| Log Kd | = | -9.63 |
| Log Kd | = | -8.41 |
| Log Kd | = | -10.12 |
| Log Kd | = | -10.08 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.00183 | Kd | = | 1.83 | nM |
| 0.00114 | Kd | = | 1.14 | nM |
| Standard Type | Activity Comment |
|---|---|
| Activity | Not Active |
| PDBbind Data Link | Affinity_Quilifier | Ki | PubMed | Protein Target | Protein Name | MMDB | PDB |
|---|---|---|---|---|---|---|---|
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mto | = | 0.11 | 12390023 | 1MTO_A,1MTO_B | 6-phosphofructokinase | 21480 | 1MTO |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mu6 | = | 0.0042 | 12570369 | 1MU6_B | thrombin alpha | 26736 | 1MU6 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mue | = | 0.0023 | 12657281 | 1MUE_B | thrombin alpha | 26738 | 1MUE |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mx1 | > | 100 | 12725862 | 1MX1_A | carboxylesterase i | 22651 | 1MX1 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1mxo | = | 0.001 | 1MXO_A | beta-lactamase | 22061 | 1MXO | |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1my8 | = | 0.035 | 1MY8_A | beta-lactamase | 22064 | 1MY8 | |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n1v | = | 140 | 12507479 | 1N1V_A | neuraminidase (sialidase) | 21810 | 1N1V |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n2v | = | 83 | 12646024 | 1N2V_A | queuine tRNA-ribosyltransferase | 22661 | 1N2V |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n3i | = | 0.0013 | 12755607 | 1N3I_A,1N3I_B | purine nucleoside phosphorylase | 24646 | 1N3I |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n46 | = | 3.0E-5 | 12565933 | 1N46_A | thyroid hormone receptor beta-1 | 22662 | 1N46 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n4h | = | 0.28 | 12958591 | 1N4H_A | nuclear receptor ror-beta | 24647 | 1N4H |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n5r | = | 2.2 | 12505979 | 1N5R_A | acetylcholinesterase | 21834 | 1N5R |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1n7i | = | 0.26 | 14695818 | 1N7I_A | phenylethanolamine n-methyltransferase | 25597 | 1N7I |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nc1 | = | 0.75 | 12496243 | 1NC1_A,1NC1_B | mta/sah nucleosidase | 25250 | 1NC1 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nc3 | = | 10 | 12496243 | 1NC3_A,1NC3_B | mta/sah nucleosidase | 22390 | 1NC3 |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nde | = | 0.015 | 12459017 | 1NDE_A | estrogen receptor beta | 21544 | 1NDE |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1ndz | = | 0.0077 | 14709046 | 1NDZ_A | adenosine deaminase | 25613 | 1NDZ |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nhv | = | 2.2 | 12509436 | 1NHV_A | rna-dependent rna polymerase | 22403 | 1NHV |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1nny | = | 0.022 | 12670229 | 1NNY_A | tyrosine phosphatase 1b | 22696 | 1NNY |
| http://www.pdbbind.org.cn/quickpdb.asp?quickpdb=1noj | = | 700 | 8652510 | 1NOJ_A | glycogen phosphorylase | 56992 | 1NOJ |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.00695 | Kd | = | 6.95 | nM |
| 0.0139 | Kd | = | 13.9 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.00184 | Kd | = | 1.84 | nM |
| 0.001 | Kd | = | 1 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 26 | IC50 | = | 26000 | nM |
| Species | Strain | IsPseudotypeVirus | AssayMeth | Target | Mutations | IC50Mod | IC50 | IC50Unit | ICOtherPct | ICOtherPctUnit | ICOtherConc | ICOtherConcUnit | KiMod | Ki | KiUnit | Km | KmUnit | HostAnalog | HostAnalogSpecies | RelResFoldChgMod | RelResFoldChg | Comments | Reference | Citation | Other Information |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3' PROCESSING | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| 3' PROCESSING | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| 3' PROCESSING | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| STRAND TRANSFER | Integrase | > | 100 | uM | 18662877 | EFFICIENT SYNTHESIS AND UTILIZATION OF PHENYL-SUBSTITUTED HETEROAROMATIC CARBOXYLIC ACIDS AS ARYL DIKETO ACID ISOSTERES IN THE DESIGN OF NOVEL HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2008, 18(16), 4521-4. | |||||||||||||||||||
| HIV-1 | dTTP incorporation assay by liquid scintillation | Reverse transcriptase | 6.2 | uM | 19442130 | CHARACTERIZATION OF HIV-1 ENZYME REVERSE TRANSCRIPTASE INHIBITION BY THE COMPOUND 6-CHLORO-1,4-DIHYDRO-4-OXO-1-(BETA-D-RIBOFURANOSYL) QUINOLINE-3-CARBOXYLIC ACID THROUGH KINETIC AND IN SILICO STUDIES. Current HIV Research 2009, 7(3), 327-335. | |||||||||||||||||||
| HIV-1 | dTTP incorporation assay by liquid scintillation | Reverse transcriptase | 5.3 | uM | 19442130 | CHARACTERIZATION OF HIV-1 ENZYME REVERSE TRANSCRIPTASE INHIBITION BY THE COMPOUND 6-CHLORO-1,4-DIHYDRO-4-OXO-1-(BETA-D-RIBOFURANOSYL) QUINOLINE-3-CARBOXYLIC ACID THROUGH KINETIC AND IN SILICO STUDIES. Current HIV Research 2009, 7(3), 327-335. | |||||||||||||||||||
| HIV-1 | dTTP incorporation assay by liquid scintillation | Reverse transcriptase | 5 | uM | 19442130 | CHARACTERIZATION OF HIV-1 ENZYME REVERSE TRANSCRIPTASE INHIBITION BY THE COMPOUND 6-CHLORO-1,4-DIHYDRO-4-OXO-1-(BETA-D-RIBOFURANOSYL) QUINOLINE-3-CARBOXYLIC ACID THROUGH KINETIC AND IN SILICO STUDIES. Current HIV Research 2009, 7(3), 327-335. | |||||||||||||||||||
| HIV-1 | N | standard reverse transcriptase assay | Reverse transcriptase | 50 | ug/mL | SYNTHESIS AND HIV-1 REVERSE TRANSCRIPTASE INHIBITION ACTIVITY OF 1,4-NAPHTHOQUINONE DERIVATIVES. Chemistry of Natural Compounds 2012, 47(6), 883-887. | |||||||||||||||||||
| STRAND TRANSFER | Integrase | > | 100 | uM | 18805696 | DISCOVERY OF 3-ACETYL-4-HYDROXY-2-PYRANONE DERIVATIVES AND THEIR DIFLUORIDOBORATE COMPLEXES AS A NOVEL CLASS OF HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry 2008, 16(19), 8988-98. | |||||||||||||||||||
| STRAND TRANSFER | Integrase | > | 100 | uM | 18805696 | DISCOVERY OF 3-ACETYL-4-HYDROXY-2-PYRANONE DERIVATIVES AND THEIR DIFLUORIDOBORATE COMPLEXES AS A NOVEL CLASS OF HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry 2008, 16(19), 8988-98. | |||||||||||||||||||
| 3'-PROCESSING | Integrase | > | 100 | uM | 18805696 | DISCOVERY OF 3-ACETYL-4-HYDROXY-2-PYRANONE DERIVATIVES AND THEIR DIFLUORIDOBORATE COMPLEXES AS A NOVEL CLASS OF HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry 2008, 16(19), 8988-98. | |||||||||||||||||||
| HIV-1 | STRAND TRANSFER | Integrase | 0.015 | uM | 19523819 | N-(4-FLUOROBENZYL)-3-HYDROXY-9;9-DIMETHYL-4-OXO-6;7;8;9-TETRAHYDRO-4H-PYRAZINO[1;2-A]PYRIMIDINE-2-CARBOXAMIDES A NOVEL CLASS OF POTENT HIV-1 INTEGRASE INHIBITORS. Bioorganic & Medical Chemistry Letters 2009, 19, 4245-9. | |||||||||||||||||||
| HIV-1 | HPLC | Protease | 5.8 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ASSAY | Reverse transcriptase | 170.3 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | HPLC | Protease | 10.2 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ASSAY | Reverse transcriptase | 33.7 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | HPLC | Protease | 24.9 | uM | 18543149 | INHIBITION OF HIV-1 PROTEASE AND RNASE H OF HIV-1 REVERSE TRANSCRIPTASE ACTIVITIES BY LONG CHAIN PHENOLS FROM THE SARCOTESTAS OF GINKGO BILOBA. Planta Medica 2008, 74(5), 532-534. | |||||||||||||||||||
| HIV-1 | 3'-processing | Integrase | > | 100 | uM | COMPOUNDS WITH HIV-1 INTEGRASE INHIBITORY ACTIVITY AND USE THEREOF AS ANTI-HIV/AIDS THERAPEUTICS. . Patent 2009, , . | |||||||||||||||||||
| HIV-1 | Strand Transfer | Integrase | > | 100 | uM | COMPOUNDS WITH HIV-1 INTEGRASE INHIBITORY ACTIVITY AND USE THEREOF AS ANTI-HIV/AIDS THERAPEUTICS. . Patent 2009, , . | |||||||||||||||||||
| HIV-1 | 3'-processing | Integrase | > | 100 | uM | COMPOUNDS WITH HIV-1 INTEGRASE INHIBITORY ACTIVITY AND USE THEREOF AS ANTI-HIV/AIDS THERAPEUTICS. . Patent 2009, , . |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| IC50 | Not Determined |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| IC50 | > | 100 | ug.mL-1 | Outside typical range |
| IC50 | = | 0.15 | ug.mL-1 | |
| IC50 | = | 10 | ug.mL-1 | |
| IC50 | > | 100 | ug.mL-1 | Outside typical range |
| IC50 | = | 20 | ug.mL-1 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.02 | Ki | = | 20 | nM |
| 0.45 | Ki | = | 450 | nM |
| 0.005 | Ki | = | 5 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 0.28184 | Ki | = | 281.84 | nM | |
| 1.202E-4 | Ki | = | 0.1202 | nM | |
| 0.04786 | Ki | = | 47.86 | nM | |
| 21.8776 | Ki | = | 21877.62 | nM | |
| 0.03548 | Ki | = | 35.48 | nM | |
| 0.005012 | Ki | = | 5.012 | nM | |
| 38.0189 | Ki | = | 38018.94 | nM | |
| 0.0257 | Ki | = | 25.7 | nM | |
| 0.002089 | Ki | = | 2.089 | nM | |
| 0.004898 | Ki | = | 4.898 | nM | |
| 0.002884 | Ki | = | 2.884 | nM | |
| 2.188E-4 | Ki | = | 0.2188 | nM | |
| 7.94328 | Ki | = | 7943.28 | nM | |
| 2.399E-4 | Ki | = | 0.2399 | nM | |
| 2.188E-4 | Ki | = | 0.2188 | nM | |
| 3.54813 | Ki | = | 3548.13 | nM | |
| 0.07943 | Ki | = | 79.43 | nM | |
| 4.46684 | Ki | = | 4466.84 | nM |
| Standard Type | Standard Units | Activity Comment |
|---|---|---|
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Inhibition | % | Not Active |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | -2 | % |
| Inhibition | = | 100 | % |
| Inhibition | = | 96 | % |
| Inhibition | = | 19 | % |
| Inhibition | = | 90 | % |
| Standard Type | Activity Comment |
|---|---|
| Activity | Not Active |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 24.1 | IC50 | = | 24100 | nM |
| 1.6 | IC50 | = | 1600 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.437 | Ki | = | 437 | nM |
| 1.1 | Ki | = | 1100 | nM |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 98.47 | % |